The Hackett Group (HCKT) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Q3 2024 total revenue was $79.8 million, up from $75.9 million in Q3 2023, exceeding guidance.
Adjusted diluted EPS was $0.43, above guidance; GAAP diluted EPS was $0.31, down from $0.34 due to non-cash compensation and acquisition-related expenses.
The acquisition of LeewayHertz, an AI-focused consulting firm, expanded GenAI capabilities and led to a joint venture for GenAI SaaS offerings.
Strong Oracle and SAP segment growth, with GenAI consulting revenue up sequentially but offset by eProcurement weakness, keeping Global S&BT flat year-over-year.
Cash flow from operations for the first nine months of 2024 increased to $27.1 million from $11.8 million prior year.
Financial highlights
Revenue before reimbursements was $77.9 million, above guidance and up from $74.6 million year-over-year.
Oracle Solutions Q3 revenue was $22.8 million, SAP Solutions $13.0 million, and Global S&BT $44.1 million, with segment profits of $5.5 million, $3.7 million, and $14.1 million, respectively.
Adjusted EBITDA was $17.7 million (22.7% of revenues before reimbursements), slightly down from 23.2% prior year.
GAAP net income was $8.6 million; adjusted net income was $12.1 million.
Cash at quarter-end was $10 million, down from $21 million at year-end 2023.
Outlook and guidance
Q4 2024 revenue before reimbursements expected between $73.5 million and $75 million.
Adjusted diluted EPS for Q4 2024 projected at $0.41–$0.43; adjusted gross margin expected at 45%–46%.
Adjusted EBITDA margin expected at 23%–24%; cash flow from operations to increase sequentially.
All segments expected to grow, with total company up 3%–5% year-over-year.
Management expects available funds and cash flows from operations to be sufficient for at least the next twelve months.
Latest events from The Hackett Group
- Annual meeting to vote on director, stock plan amendment, compensation, and auditor ratification.HCKT
Proxy filing20 Mar 2026 - Proxy covers director election, compensation, stock plan amendment, and auditor ratification.HCKT
Proxy filing20 Mar 2026 - Q4 2025 beat guidance with SAP and GenAI gains, but margins and EBITDA declined year-over-year.HCKT
Q4 202517 Feb 2026 - Q2 revenue and EPS exceeded guidance, with Gen AI investments and strong cash flow.HCKT
Q2 20242 Feb 2026 - Q4 results beat guidance on SAP and GenAI strength; GenAI investments to drive 2025 growth.HCKT
Q4 202423 Dec 2025 - Shareholders will vote on director elections, stock plan expansion, executive pay, and auditor ratification.HCKT
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, stock plan amendment, compensation, and auditor.HCKT
Proxy Filing2 Dec 2025 - Q2 revenue up 1.6% to $78.9M; Gen AI drives growth, but costs weigh on net income.HCKT
Q2 202523 Nov 2025 - GenAI-fueled growth drove strong Q1 results, despite lower net income from higher expenses.HCKT
Q1 202521 Nov 2025